Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

Presentation TCT India 2025

Beyond the Angiogram: How CFR & IMR Revealed the True cause of my Patients’ Angina

Presenter: Sripal Bangalore

July 25, 2025

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

News Daily News

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

Caitlin E. Cox

January 08, 2024

Presentation TCT 2023

TCT 757: Accuracy of pressure-derived coronary flow reserve (CFR) compared with continuous thermodilution in patients with coronary microvascular dysfunction.

Presenter: Daniel Munhoz

October 25, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

Presentation TCT 2022

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

Presenter: Tijn Jansen

September 19, 2022

News Conference News ACC 2022

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

Caitlin E. Cox

April 02, 2022

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Conference News TCT 2020

FFR Insights Before and After PCI: Fresh Food for Thought

Caitlin E. Cox

October 16, 2020

$Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation$

Presentation TCT 2019

Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation

Presenter: Matjaz Bunc

September 27, 2019

Presentation iTOP 2019

Flujo absoluto coronario

Presenter: Fernando Rivero

June 04, 2019

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

Yael L. Maxwell

March 08, 2018

Presentation iASSESS 2017

FFR, CFR, and PCI

Presenter: Arnold Seto

August 30, 2017

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Industry News

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

January 26, 2016

News Daily News

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

Yael L. Maxwell

September 23, 2015

News Daily News

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Yael L. Maxwell

September 23, 2015

News Industry News

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

June 10, 2015

News Daily News

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

May 07, 2014

Advertisement

Beyond the Angiogram: How CFR & IMR Revealed the True cause of my Patients’ Angina

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Exercise Testing in ANOCA Uncovers Microvascular Dysfunction

TCT 757: Accuracy of pressure-derived coronary flow reserve (CFR) compared with continuous thermodilution in patients with coronary microvascular dysfunction.

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

TCT 303: Continuous versus bolus thermodilution derived CFR and MRR and their association with symptoms of CMD: a head-to-head comparison

In ANOCA, Diltiazem Fails to Improve Vasomotor Function: EDIT-CMD

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

FFR Insights Before and After PCI: Fresh Food for Thought

Slovenia Presents: Multimodal Treatment of Refractory Angina Pectors With CFR (Coronary Flow Reducer) Implantation

Flujo absoluto coronario

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

CABG Bests PCI for 5-Year Survival in Biggest Analysis Yet, With Options for Left Main Disease

FFR, CFR, and PCI

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

与预期相反，研究发现冠状动脉微血管功能障碍无性别差异

Contrary to Expectations, Study Finds No Sex Difference in Coronary Microvascular Dysfunction

Interventional Cardiovascular Device Development: Considerations in Clinical Trial Implementation

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content